Engineering & Entrepreneurship

Globalization is redefining the face of commercial enterprise, the roles of developing countries, and the power of individuals. Changing business practices and technological capabilities have had lasting effects on the future competitiveness of both established and emerging economies.

With financial support from the Kauffman Foundation, the Duke GVC Center engaged in research on engineering and entrepreneurship between 2006 and 2010. The research projects dealt with the state of engineering education competitiveness in the United States, the phenomenon of immigrant entrepreneurship, and sources of innovation and workforce development in varied overseas locations, such as India and China.

A narrow band of firms in China and India in particular are utilizing top talent to explore high-value research and development, and design work rather than low-skilled outsourcing activities. As these trends evolve, the United States, which is known as a fertile startup environment with strong contributions from skilled immigrants, may have difficulty retaining and attracting future generations of immigrant entrepreneurs due to current visa policies. To understand and explore these issues, the Global Engineering and Entrepreneurship (GEE) research group conducted studies on a range of topics, including:

The Global Engineering and Entrepreneurship @ Duke research group consists of an interdisciplinary team of engineers, sociologists, and industry experts. Many of the individuals involved in this research have interests in corporate management, global economics and intellectual property http://www.soc.duke.edu/GlobalEngineering.

Powder coating: A global value chain perspective

The American Brain Drain and Asia

This paper examines what motivates individuals from different parts of the world to come to the United States.

The American Brain Drain and Asia

This paper examines what motivates individuals from different parts of the world to come to the United States.

Work Visa Numbers Get Squishy

Research conducted at Duke University contributes to study that shows both sides in the debate over employee immigration policies misuse data to advance their positions on the issue.

Is the U.S. Experiencing its First Brain Drain?

The United States has long served as a magnet for the world’s talented scientists, engineers and mathematicians. But, this trend may now be reversing and the United States may be experiencing the first brain drain in its history.

America’s Loss is the World’s Gain: America’s New Immigrant Entrepreneurs: Part IV

This paper attempts to answer questions on immigration and entrepreneurship through a survey of 1,203 Indian and Chinese immigrants who had worked or received their education in the United States and returned to their home country.

America’s Loss is the World’s Gain: America’s New Immigrant Entrepreneurs: Part IV

This paper attempts to answer questions on immigration and entrepreneurship through a survey of 1,203 Indian and Chinese immigrants who had worked or received their education in the United States and returned to their home country.

How the Disciple Became the Guru

This paper is based on detailed interviews with the CEOs, HR executives, R&D managers, and employees of 24 leading companies in rapidly growing sectors in India. The authors present an overview of best practices.

The Globalization of Innovation: Can India and China Cure the Global Pharmaceutical Market?

Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These relationships largely appear to be symbiotic. As a result of the movement of research to their countries, Indian and Chinese scientists are rapidly developing the ability to innovate and create their own intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments of the pharmaceutical global value chain. This research was funded in part by the Ewing Marion Kauffman Foundation.